Cost-utility analysis of the fixed-dose combination of dolutegravir/abacavir/lamivudine as initial treatment of HIV+ patients in Spain

Objective: Fixed-dose combinations of antiretroviral drugs have meant an important step forward in simplifying treatment and improving compliance and has led to an increased effectiveness of therapy, a viral load decrease and improving the quality of life of patients. The single-table formulation of...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Santiago Moreno Guillen, Juan Emilio Losa García, Juan Berenguer Berenguer, José Manuel Martínez Sesmero, Santiago Cenoz Gomis, Ruth Graefenhain, David Lopez Sanchez-Cambronero, Francisco Javier Parrondo Garcia
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2017-09-01
Colecção:	Farmacia Hospitalaria
Assuntos:	HIV treatment Computer simulation Cost-Utility analysis
Acesso em linha:	http://www.aulamedica.es/fh/pdf/10808.pdf
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!